Q2 FY2026 · ended Jun 30, 2026 · Revenue $0 · Filed Aug 14, 2026
Acro Biomedical Co., Ltd. (ACBM) files with the SEC under industry code 7900, Services-Amusement & Recreation Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $0 and a net loss of $21,356.
Revenue
$0
Net income
$-21,356
-37.2% vs year-ago quarter
Operating cash flow
$-10,504
+88.8% vs year-ago quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
60.04M
+0.0% vs year-ago quarter
Net cash
$4,098
Q4 FY2025
Operating margin
—
Company profile
- Industry
- Services-Amusement & Recreation Services (SIC 7900)
- Listed as
- ACBM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fishers, IN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1622996
- Former names
- KILLER WAVES HAWAII, INC (until Jan 30, 2017)
Other Services-Amusement & Recreation Services companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$17,554 | -$60,271 | -$16,377 | -$115,099 | -$13,614 |
| Net income | -$21,356 | -$43,774 | $42,526 | -$117,809 | -$15,562 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | -$10,504 | -$49,821 | -$25,377 | -$54,410 | -$93,984 |
| Total assets | $3,648 | $3,873 | $14,098 | $4,323 | $53,277 |
| Stockholders' equity | -$444,789 | -$427,235 | -$386,964 | -$432,619 | -$317,520 |
| Cash and investments | $3,648 | $3,873 | $4,098 | $4,323 | $26 |
| Total debt | — | — | $0 | $0 | $13,651 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Sep 2, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Jan 8, 2026 | Jan 4, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
All 91 Acro Biomedical Co., Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.